Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aytu Biopharma (AYTU) Operating Leases: 2020-2021

Historic Operating Leases for Aytu Biopharma (AYTU) over the last 2 years, with Jun 2021 value amounting to $2.6 million.

  • Aytu Biopharma's Operating Leases fell 36.40% to $2.4 million in Q1 2022 from the same period last year, while for Mar 2022 it was $2.4 million, marking a year-over-year decrease of 36.40%. This contributed to the annual value of $2.6 million for FY2021, which is 261.93% up from last year.
  • Per Aytu Biopharma's latest filing, its Operating Leases stood at $2.6 million for FY2021, which was up 261.93% from $725,000 recorded in FY2020.
  • Aytu Biopharma's 5-year Operating Leases high stood at $2.6 million for FY2021, and its period low was $725,000 during FY2020.
  • Its 2-year average for Operating Leases is $1.7 million, with a median of $1.7 million in 2020.
  • Data for Aytu Biopharma's Operating Leases shows a peak YoY spiked of 261.93% (in 2021) over the last 5 years.
  • Aytu Biopharma's Operating Leases (Yearly) stood at $725,000 in 2020, then surged by 261.93% to $2.6 million in 2021.